These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 121328

  • 21. Further characterization of the three-choice morphine, cyclazocine and saline discrimination paradigm: opioids with agonist and antagonist properties.
    White JM, Holtzman SG.
    J Pharmacol Exp Ther; 1983 Jan; 224(1):95-9. PubMed ID: 6336785
    [Abstract] [Full Text] [Related]

  • 22. Interactions between narcotic agonists, partial agonists andd antagonists evaluated by punished an unpunished behavior in the rat.
    Snell D, Harris RA.
    Psychopharmacology (Berl); 1982 Jan; 76(2):177-81. PubMed ID: 6281840
    [Abstract] [Full Text] [Related]

  • 23. Involvement of mu-receptors in the opioid-induced generation of bursting discharges in hippocampal pyramidal cells.
    Gähwiler BH, Maurer R.
    Regul Pept; 1981 May; 2(2):91-6. PubMed ID: 6265981
    [Abstract] [Full Text] [Related]

  • 24. Stereospecificity of mixed-action opioid agonist/antagonists in morphine-tolerant squirrel monkeys.
    Dykstra LA, Picker MJ, Powell K.
    NIDA Res Monogr; 1990 May; 105():375. PubMed ID: 1876046
    [No Abstract] [Full Text] [Related]

  • 25. Effects of opioid agonist drugs on the in vitro release of 3H-GABA, 3H-dopamine and 3H-5HT from slices of rat globus pallidus.
    Dewar D, Jenner P, Marsden CD.
    Biochem Pharmacol; 1987 May 15; 36(10):1738-41. PubMed ID: 3297065
    [No Abstract] [Full Text] [Related]

  • 26. Phencyclidine-like discriminative stimulus properties of opioids in the squirrel monkey.
    Holtzman SG.
    Psychopharmacology (Berl); 1982 May 15; 77(4):295-300. PubMed ID: 6813889
    [Abstract] [Full Text] [Related]

  • 27. Quaternary naltrexone: evidence for the central mediation of discriminative stimulus effects of narcotic agonists and antagonists.
    Valentino RJ, Herling S, Woods JH, Medzihradsky F, Merz H.
    J Pharmacol Exp Ther; 1981 Jun 15; 217(3):652-9. PubMed ID: 6262493
    [No Abstract] [Full Text] [Related]

  • 28. Naltrexone discrimination in morphine-treated monkeys.
    France CP, Woods JH.
    NIDA Res Monogr; 1989 Jun 15; 95():298-9. PubMed ID: 2640973
    [No Abstract] [Full Text] [Related]

  • 29. Physiological and behavioral approaches to the study of the quasi-morphine withdrawal syndrome.
    Valentino RJ, Smith CB, Woods JH.
    Fed Proc; 1981 Apr 15; 40(5):1502-7. PubMed ID: 7194193
    [Abstract] [Full Text] [Related]

  • 30. Inhibition of neuronally induced relaxation of canine lower esophageal sphincter by opioid peptides.
    Barnette MS, Grous M, Manning CD, Callahan JF, Barone FC.
    Eur J Pharmacol; 1990 Jul 03; 182(2):363-8. PubMed ID: 2204537
    [Abstract] [Full Text] [Related]

  • 31. Discriminative stimulus effects of naltrexone in narcotic-naive and morphine-treated pigeons.
    Valentino RJ, Herling S, Woods JH.
    J Pharmacol Exp Ther; 1983 Feb 03; 224(2):307-13. PubMed ID: 6681632
    [No Abstract] [Full Text] [Related]

  • 32. Delta opioid-like discriminative stimulus effects of mu opioids in pigeons discriminating the delta opioid BW373U86 from saline.
    Picker MJ, Cook CD.
    Behav Pharmacol; 1998 Jul 03; 9(4):319-28. PubMed ID: 10065920
    [Abstract] [Full Text] [Related]

  • 33. Effects of ketazocine, ethylketazocine and phenazocine on schedule-controlled behavior: antagonism by naloxone.
    Leander JD.
    Neuropharmacology; 1982 Sep 03; 21(9):923-8. PubMed ID: 6128693
    [Abstract] [Full Text] [Related]

  • 34. Discriminative stimulus effects of mu and kappa opioids in the pigeon: analysis of the effects of full and partial mu and kappa agonists.
    Picker MJ, Dykstra LA.
    J Pharmacol Exp Ther; 1989 May 03; 249(2):557-66. PubMed ID: 2566680
    [Abstract] [Full Text] [Related]

  • 35. Reinforcing properties of stereoisomers of the putative sigma agonists N-allylnormetazocine and cyclazocine in rhesus monkeys.
    Slifer BL, Balster RL.
    J Pharmacol Exp Ther; 1983 Jun 03; 225(3):522-8. PubMed ID: 6306209
    [Abstract] [Full Text] [Related]

  • 36. An in vivo pharmacological analysis of benzomorphan binding sites in rats.
    Cowan A, Gmerek DE.
    NIDA Res Monogr; 1984 Mar 03; 49():114-20. PubMed ID: 6090914
    [No Abstract] [Full Text] [Related]

  • 37. Opiate agonist-antagonist interactions: application of a three-key drug discrimination procedure.
    France CP, Woods JH.
    J Pharmacol Exp Ther; 1985 Jul 03; 234(1):81-9. PubMed ID: 4009506
    [Abstract] [Full Text] [Related]

  • 38. Opioid receptor agonists D-Ala-2-Me-Phe-4-Met-(O)-ol enkephalin and ethylketocyclazocine in the brain accentuate digoxin-induced arrhythmias.
    Rabkin SW.
    Can J Cardiol; 1992 Jul 03; 8(6):631-8. PubMed ID: 1504916
    [Abstract] [Full Text] [Related]

  • 39. Metaphit, a proposed phencyclidine receptor acylator: phencyclidine-like behavioral effects and evidence of absence of antagonist activity in pigeons and in rhesus monkeys.
    Koek W, Woods JH, Jacobson AE, Rice KC, Lessor RA.
    J Pharmacol Exp Ther; 1986 May 03; 237(2):386-92. PubMed ID: 3009781
    [Abstract] [Full Text] [Related]

  • 40. Effect of a met-enkephalin analogue and naloxone infusion on gonadotrophin secretion in man.
    Delitala G, Giusti M, Devilla L, Mazzocchi G, Lotti G, Giordano G.
    Acta Eur Fertil; 1981 Sep 03; 12(3):287-8. PubMed ID: 6803502
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.